{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:10:30Z","timestamp":1782961830911,"version":"3.54.5"},"reference-count":138,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.3934\/molsci.2017.4.446","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T01:52:51Z","timestamp":1509069171000},"page":"446-462","source":"Crossref","is-referenced-by-count":5,"title":["Calpain inhibition as a possible new therapeutic target in multiple sclerosis"],"prefix":"10.3934","volume":"4","author":[{"given":"Amena","family":"W. Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"1 Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapan","family":"K. Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabinda","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenkichi","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baerbel","family":"Rohrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren","family":"L. Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"2 Department of Pathology, Microbiology and Immunology, University of South Carolina, Columbia, SC, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"3 Department of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"4 Department of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"5 Research Service, Ralph H. Johnson VA Medical Center, Charleston, SC, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2321","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci7070078","article-title":"Multiple Sclerosis: Immunopathology and Treatment Update","author":"Dargahi N, Katsara M, Tselios T, et al.","journal-title":"<em>Brain Sci<\/em>"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00014-5","article-title":"The clinical course of multiple sclerosis","author":"Confavreux C, Vukusic S","journal-title":"<em>Handb Clin Neurol<\/em>"},{"key":"3","article-title":"Relapses and progression of disability in multiple sclerosis","unstructured":"3. Confavreux C, Vukusic S, Moreau T, et al. (2001) Relapses and progression of disability in multiple sclerosis. <em>N Engl J Med<\/em> 343: 1430-1438."},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0396-6","article-title":"B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence","author":"Kinzel S, Weber MS","journal-title":"<em>Cns Drug<\/em>"},{"key":"5","article-title":"Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors","unstructured":"5. Fernando NT, Koch M, Rothrock C, et al. (2008) Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. <em>Clin Cancer Res <\/em>14: 1529-1539."},{"key":"6","article-title":"Stepchild or Prodigy","unstructured":"6. Rottlaender A, Kuerten S. (2015) Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research. <em>Int J Mol Sci <\/em>16: 14850-14865."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304094","article-title":"Brain atrophy and lesion load predict long term disability in multiple sclerosis","author":"Popescu V, Agosta F, Hulst HE, et al.","journal-title":"<em>J Neurol Neurosur Psychiatr<\/em>"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2009.08.004","article-title":"Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system","author":"Vickers JC, King AE, Woodhouse A, et al.","journal-title":"<em>Brain Res Bull<\/em>"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0530-6","article-title":"Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities","author":"Mentis AA, Dardiotis E, Grigoriadis N, et al.","journal-title":"<em>Mol neurobiol<\/em>"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.04.007","article-title":"Microbial view of central nervous system autoimmunity","author":"Berer K, Krishnamoorthy G","journal-title":"<em>FEBS lett<\/em>"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.04.006","article-title":"The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance","author":"Geginat J, Paroni M, Pagani M, et al.","journal-title":"<em>Trend in Immunol<\/em>"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2014.02.026","article-title":"Clinically isolated syndromes and the relationship to multiple sclerosis","author":"Brownlee WJ, Miller DH","journal-title":"<em>J Clin Neurosci<\/em>"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015150532","article-title":"Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study","author":"Rocca MA, Preziosa P, Mesaros S, et al.","journal-title":"<em>Radiology<\/em>"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000189","article-title":"Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis","author":"Klaver R, Popescu V, Voorn P, et al.","journal-title":"<em>J Neuropathol Exp Neurol<\/em>"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e24136","article-title":"Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes","author":"De SN, Giorgio A, Battaglini M, et al.","journal-title":"<em>Neurology<\/em>"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","author":"Alonso A, Hern\u00e1n MA","journal-title":"<em>Neurology<\/em>"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20160015","article-title":"Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact","author":"Rojas JI, Patrucco L, Miguez J, et al.","journal-title":"<em>Arq Neuro-Psiquiat<\/em>"},{"key":"18","article-title":"[Brain atrophy in clinically isolated syndrome]","unstructured":"18. Rojas JI, Patrucco L, Besada C, et al. (2010) [Brain atrophy in clinically isolated syndrome]. <em>Neurolog\u00eda<\/em> 25: 430-434."},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304301","article-title":"Optical coherence tomography shows retinal abnormalities associated with optic nerve disease","author":"Tawse KL, Gobuty M, Mendoza-Santiesteban C","journal-title":"<em>Br J Ophthalmol<\/em>"},{"key":"20","article-title":"Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss","unstructured":"20. You Y, Gupta VK, Li JC, et al. (2013) Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss. <em>Rev Neurosci<\/em> 24: 301-321."},{"key":"21","article-title":"Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma","unstructured":"21. Namekata K, Kimura A, Kawamura K, et al. (2013) Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma. <em>Cell Death Diff <\/em>20: 1250-1256."},{"key":"22","article-title":"Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis","unstructured":"22. Burkholder BM, Osborne B, Loguidice MJ, et al. (2009) Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. <em>Arch Neurol<\/em> 66: 1366."},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.04.010","article-title":"Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study","author":"Frohman EM, Dwyer MG, Frohman T, et al.","journal-title":"<em>J Neurol Sci<\/em>"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.01.023","article-title":"One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis","author":"Pineles SL, Birch EE, Talman LS, et al.","journal-title":"<em>Am J Ophthalmol<\/em>"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.10.040192.001101","article-title":"Immunological aspects of demyelinating diseases","author":"Martin R, Mcfarland HF, Mcfarlin DE","journal-title":"<em>Annu Rev Immunol<\/em>"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis","author":"Hobom M, Storch MK, Weissert R, et al.","journal-title":"<em>Brain Pathol<\/em>"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.06.010","article-title":"Mouse models for multiple sclerosis: historical facts and future implications","author":"Croxford AL, Kurschus FC, Waisman A","journal-title":"<em>Biochim Biophys Acta<\/em>"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19990301)55:5<533::AID-JNR1>3.0.CO;2-8","article-title":"Pathophysiological role of calpain in experimental demyelination","author":"Shields DC, Banik NL","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.08.005","article-title":"A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis","author":"Hassen GW, Feliberti J, Kesner L, et al.","journal-title":"<em>J Neuroimmunol<\/em>"},{"key":"30","article-title":"Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis","unstructured":"30. Guyton MK, Das A, Samantaray S, et al. (2010) Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. <em>J Neurosci Res<\/em> 88: 2398-2408."},{"key":"31","article-title":"Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects","unstructured":"31. Kobeissy FH. (2015) Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Crc Press."},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.03.009","article-title":"CaSR and calpain contribute to the ischemia reperfusion injury of spinal cord","author":"Sun JF, Yang HL, Huang YH, et al.","journal-title":"<em>Neurosci lett<\/em>"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12374","article-title":"Critical role of calpain in spinal cord degeneration in Parkinson's disease","author":"Samantaray S, Knaryan VH, Shields DC, et al.","journal-title":"<em>J Neurochem<\/em>"},{"key":"34","article-title":"Cysteine proteases as therapeutic targets: does selectivity matter","unstructured":"34. Siklos M, Benaissa M, Thatcher GRJ (2015) Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. <em>Acta pharmaceutica Sinica B<\/em> 5: 506-519."},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13770","article-title":"Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis","author":"Smith AW, Rohrer B, Wheless L, et al.","journal-title":"<em>J Neurochem<\/em>"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2011.08.005","article-title":"Calpains: an elaborate proteolytic system","author":"Ono Y, Sorimachi H","journal-title":"<em>Biochim Biophys Acta<\/em>"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb19378.x","article-title":"Structural and functional aspects of calcium homeostasis in eukaryotic cells","author":"Pietrobon D, Di VF, Pozzan T","journal-title":"<em>Eur J Biochem<\/em>"},{"key":"38","article-title":"Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder","unstructured":"38. Wu HY, Tomizawa K, Matsui H (2007) Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder. <em>Acta Medica Okayama<\/em> 61: 123-137."},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0045-0","article-title":"Protein co-expression with axonal injury in multiple sclerosis plaques","author":"Diaz-Sanchez M, Williams K, Deluca GC, et al.","journal-title":"<em>Acta Neuropathol<\/em>"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006705","article-title":"Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction","author":"Yan F, Sun W, Shi Y, et al.","journal-title":"<em>Plos One<\/em>"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490370408","article-title":"Peptide bond specificity of calpain: proteolysis of human myelin basic protein","author":"Banik NL, Chou CH, Deibler GE, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1038\/srep28699","article-title":"Neuroprotection mediated by inhibition of calpain during acute viral encephalitis","author":"Howe CL, Lafrancecorey RG, Mirchia K, et al.","journal-title":"<em>Sci Rep<\/em>"},{"key":"43","article-title":"Involvement of calpains in adult neurogenesis: implications for stroke","unstructured":"43. Machado VM, Morte MI, Carreira BP, et al. (2015) Involvement of calpains in adult neurogenesis: implications for stroke. <em>Front Cell Neurosci<\/em> 9: 22."},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12629","article-title":"SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone","author":"Knaryan VH, Samantaray S, Park S, et al.","journal-title":"<em>J Neurochem<\/em>"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.2174\/0929867003374129","article-title":"A survey of calpain inhibitors","author":"Donkor IO","journal-title":"<em>Curr Med Chem<\/em>"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2005.04.059","article-title":"Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site","author":"Shirasaki Y, Miyashita H, Yamaguchi M, et al.","journal-title":"<em>Bioorg Med Chem<\/em>"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(00)00518-7","article-title":"Synthesis and calpain inhibitory activity of alpha-ketoamides with 2,3-methanoleucine stereoisomers at the P2 position","author":"Donkor IO, Zheng X, Miller DD","journal-title":"<em>Bioorg Med Chem Lett<\/em>"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.2174\/138161206775474314","article-title":"Calpain inhibition: a therapeutic strategy targeting multiple disease states","author":"Carragher NO","journal-title":"<em>Curr Pharm Design<\/em>"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1042\/bj2010189","article-title":"L-trans-Epoxysuccinyl-leucylamido (4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L","author":"Barrett AJ, Kembhavi AA, Brown MA, et al.","journal-title":"<em>Biochem J<\/em>"},{"key":"50","article-title":"Calpain: new perspectives in molecular diversity and physiological-pathological involvement","unstructured":"50. Saido TC, Sorimachi H, Suzuki K (1994) Calpain: new perspectives in molecular diversity and physiological-pathological involvement. <em>FASEB J<\/em> 8: 814-822."},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13774","article-title":"Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation","author":"Podbielska M, Das A, Smith AW, et al.","journal-title":"<em>J Neurochem<\/em>"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2012.12.022","article-title":"Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosis-inducing factor in aldosterone-induced primary cultured cardiomyocytes","author":"Xiao T, Zhang Y, Wang Y, et al.","journal-title":"<em>Food Chem Toxicol<\/em>"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-013-1628-4","article-title":"Protective effect of S-allyl-L-cysteine against endoplasmic reticulum stress-induced neuronal death is mediated by inhibition of calpain","author":"Imai T, Kosuge Y, Endo-Umeda K, et al.","journal-title":"<em>Amino Acids<\/em>"},{"key":"54","article-title":"Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia","unstructured":"54. Li H, Zhang N, Sun G, et al. (2013) Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia. <em>ASN Neuro<\/em> 5: 195."},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10414","article-title":"Calpain and calpastatin expression in primary oligodendrocyte culture: preferential localization of membrane calpain in cell processes","author":"Ray SK, Neuberger TJ, Deadwyler G, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2006.02.051","article-title":"Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx","author":"Das A, Garner DP, Del Re AM, et al.","journal-title":"<em>Brain Res<\/em>"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.06287.x","article-title":"Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells","author":"Guyton MK, Brahmachari S, Das A, et al.","journal-title":"<em>J Neurochem<\/em>"},{"key":"58","article-title":"Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis","unstructured":"58. Guyton MK, Das A, Samantaray S, et al. (2010) Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. <em>J Neurosci Res<\/em> 88: 2398-2408."},{"key":"59","article-title":"Developments in the design and synthesis of calpain inhibitors","unstructured":"59. Neffe AT, Abell AD (2005) Developments in the design and synthesis of calpain inhibitors. <em>Curr Opin Drug Discov Develop<\/em> 8: 684-700."},{"key":"60","article-title":"Calpain activation in apoptosis of ventral spinal cord 4","unstructured":"60. Das A, Sribnick EA, Wingrave JM, et al. (2005) Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. <em>J Neurosci Res<\/em> 81: 551-562."},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1080\/02713680601161238","article-title":"Sustained elevation of intracellular cGMP causes oxidative stress triggering calpain-mediated apoptosis in photoreceptor degeneration","author":"Sharma A1","journal-title":"<em>Curr Eye Res<\/em>"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.4819","article-title":"Effect of glutamate on lysosomal membrane permeabilization in primary cultured cortical neurons","author":"Min Y, Zhu W, Zheng X, et al.","journal-title":"<em>Mol Med Rep<\/em>"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2006.22.417","article-title":"Retinal penetration of calpain inhibitors in rats after oral administration","author":"Shirasaki Y, Yamaguchi MH","journal-title":"<em>J Ocul Pharmacol Ther<\/em>"},{"key":"64","article-title":"A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-met hylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice","unstructured":"64. Koumura A, Nonaka Y, Hyakkoku K, et al. (2008). A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-met hylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. <em>Neurosci <\/em>157: 309-318."},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7497","article-title":"Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells","author":"Nakajima E, Hammond KB, Rosales JL, et al.","journal-title":"<em>Invest Ophthalmol Vis Sci<\/em>"},{"key":"66","article-title":"The Involvement of Calpain in CD4+ T Helper Cell Bias in Multple Sclerosis","unstructured":"66. Trager N, Butler JT, Haque A, et al. (2013) The Involvement of Calpain in CD4+ T Helper Cell Bias in Multple Sclerosis. <em>J Clin Cell Iimmunol<\/em> 4: 1000153."},{"key":"67","article-title":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation","unstructured":"67. Surh YJ, Chun KS, Cha HH, et al. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. <em>Mutat Res<\/em> s480-481: 243-268."},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2016.11.009","article-title":"Calpain inhibition decreases inflammatory protein expression in vessel walls in a model of chronic myocardial ischemia","author":"Potz BA, Sabe AA, Elmadhun NY, et al.","journal-title":"<em>Surgery<\/em>"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21882","article-title":"Involvement of calpain in the process of Jurkat T cell chemotaxis","author":"Butler JT, Samantaray S, Beeson CC, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"70","article-title":"Roles of calpain-calpastatin system (CCS) in human T cell activation","unstructured":"70. Mikosik A, Jasiulewicz A, Daca A, et al. (2016) Roles of calpain-calpastatin system (CCS) in human T cell activation. <em>Oncotarget<\/em> 7: 76479-76495."},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2014.09.018","article-title":"Calpains and cancer: friends or enemies","author":"Moretti D, Del BB, Allavena G, et al.","journal-title":"<em>Arch Biochem Biophys<\/em>"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490420214","article-title":"Calpain secreted by activated human lymphoid cells degrades myelin","author":"Deshpande RV, Goust JM, Hogan EL, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1159\/000441024","article-title":"Erythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia","author":"Jantzie LL, Winer JL, Corbett CJ, et al.","journal-title":"<em>Dev Neurosci<\/em>"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1344.005","article-title":"A role for calpain in optic neuritis","author":"Guyton MK, Sribnick EA, Ray SK, et al.","journal-title":"<em>Ann NY Acad Sci<\/em>"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2219-05.2006","article-title":"Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents","author":"Cerghet M, Skoff RP, Bessert D, et al","journal-title":"<em>J Neurosci<\/em>"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123130","article-title":"Calpain inhibitor PD150606 attenuates glutamate induced spiral ganglion neuron apoptosis through apoptosis inducing factor pathway in vitro","author":"Ding ZJ, Chen X, Tang XX, et al.","journal-title":"<em>PLoS One<\/em>"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21737","article-title":"Time-dependent increases in protease activities for neuronal apoptosis in spinal cords of Lewis rats during development of acute experimental autoimmune encephalomyelitis","author":"Das A, Guyton MK, Matzelle DD, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-008-8036-x","article-title":"Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration","author":"Vosler PS, Brennan CS, Chen J","journal-title":"<em>Mol Neurobiol<\/em>"},{"key":"79","doi-asserted-by":"publisher","DOI":"10.1023\/B:NERE.0000026410.56000.dd","article-title":"The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites","author":"Schaecher K, Goust JM, Banik NL","journal-title":"<em>Neurochem Res<\/em>"},{"key":"80","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80175-1","article-title":"The regulation and roles of Rel\/NF-kappa B transcription factors during lymphocyte activation","author":"Gerondakis S, Grumont R, Rourke I, et al.","journal-title":"<em>Curr Opin Immunol<\/em>"},{"key":"81","article-title":"Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells","unstructured":"81. Miyazaki T, Taketomi Y, Saito Y, et al. (2015) Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells. <em>Circ Res <\/em>116: 1170-1181."},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02549.x","article-title":"PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model","author":"Datta R, Naura AS, Zerfaoui M, et al.","journal-title":"<em>Allergy<\/em>"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-166553","article-title":"PRELI is a mitochondrial regulator of human primary T-helper cell apoptosis, STAT6, and Th2-cell differentiation","author":"Tahvanainen J, Kallonen T, L\u00e4hteenm\u00e4ki H, et al.","journal-title":"<em>Blood<\/em>"},{"key":"84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.2004.04424.x","article-title":"Regulation of STAT signalling by proteolytic processing","author":"Hendry L, John S","journal-title":"<em>Eur J Biochem<\/em>"},{"key":"85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015090","article-title":"Calpain 2 controls turnover of LFA-1 adhesions on migrating T lymphocytes","author":"Svensson L, Mcdowall A, Giles K M, et al.","journal-title":"<em>PLoS One<\/em>"},{"key":"86","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.140.3.699","article-title":"LFA-1-mediated adhesion is regulated by cytoskeletal restraint and by a Ca2+-dependent protease, calpain","author":"Stewart MP, Mcdowall A, Hogg N","journal-title":"<em> J cell Biol<\/em>"},{"key":"87","article-title":"LFA-1 to LFA-1 signals involve zeta-associated protein-70 (ZAP-70) tyrosine kinase: relevance for invasion and migration of a T cell hybridoma","unstructured":"87. Soede RD, Driessens MH, Ruulsvan SL, et al. (1999) LFA-1 to LFA-1 signals involve zeta-associated protein-70 (ZAP-70) tyrosine kinase: relevance for invasion and migration of a T cell hybridoma. <em>J Immunol<\/em> 163: 4253-4261."},{"key":"88","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.11.015","article-title":"Post-translational modifications of naturally processed MHC-binding epitopes","author":"Engelhard VH, Altrich-Vanlith M, Ostankovitch M, et al.","journal-title":"<em>Curr Opin Immunol<\/em>"},{"key":"89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2007.07.016","article-title":"Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients","author":"Imam SA, Guyton MK, Haque A, et al.","journal-title":"<em>J Neuroimmunol<\/em>"},{"key":"90","article-title":"Therapeutic Efficacy of E-64-d, a Selective Calpain Inhibitor, in Experimental Acute Spinal Cord Injury","unstructured":"90. Zhang Z, Huang Z, Dai H, et al. (2015) Therapeutic Efficacy of E-64-d, a Selective Calpain Inhibitor, in Experimental Acute Spinal Cord Injury. <em>BioMed Res Int<\/em>: 134242."},{"key":"91","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1994.11.533","article-title":"Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury","author":"Posmantur R, Hayes RL, Dixon CE, et al.","journal-title":"<em>J Neurotrauma<\/em>"},{"key":"92","doi-asserted-by":"publisher","DOI":"10.1038\/srep37050","article-title":"Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration","author":"Zhang JN, Michel U, Lenz C, et al.","journal-title":"<em>Sci Rep<\/em>"},{"key":"93","article-title":"Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA\/2J Mouse Model of Glaucoma","unstructured":"93. Wilson GN, Smith MA, Inman DM, et al. (2016) Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA\/2J Mouse Model of Glaucoma. <em>Front  Neurosci<\/em> 10: 494."},{"key":"94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.7.2628","article-title":"Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration","author":"Saito K, Elce JS, Hamos E, et al.","journal-title":"<em>Proc Natl Acad Sci USA<\/em>"},{"key":"95","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(97)05213-1","article-title":"Cell death and birth in multiple sclerosis brain","author":"Dowling P, Husar W, Menonna J, et al.","journal-title":"<em>J Neurol Sci<\/em>"},{"key":"96","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.299","article-title":"Autophagy fails to prevent glucose deprivation\/glucose reintroduction-induced neuronal death due to calpain-mediated lysosomal dysfunction in cortical neurons","author":"Ger\u00f3nimoolvera C, Montiel T, Rinconheredia R, et al.","journal-title":"<em>Cell Death Disease<\/em>"},{"key":"97","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.A117.401037","article-title":"Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line","author":"Sharma AK, Rohrer B","journal-title":"<em>J Biol Chem<\/em>"},{"key":"98","doi-asserted-by":"publisher","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","author":"Pitt D, Werner P, Raine CS","journal-title":"<em>Nat Med<\/em>"},{"key":"99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.20.11486","article-title":"A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain","author":"Shields DC, Banik NL","journal-title":"<em>Proc Natl Acad Sci USA<\/em>"},{"key":"100","doi-asserted-by":"publisher","DOI":"10.4238\/2015.October.28.17","article-title":"Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats","author":"Zhang ZW, Qin XY, Che FY, et al.","journal-title":"<em>Genetics and molecular research: GMR<\/em>"},{"key":"101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1433000100","article-title":"Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin","author":"Kivis\u00e4kk P, Mahad DJ, Callahan MK, et al.","journal-title":"<em>Proc Natl Acad Sci USA<\/em>"},{"key":"102","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.01.007","article-title":"The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal","author":"Lassmann H, Ransohoff RM","journal-title":"<em>Trends Immunol<\/em>"},{"key":"103","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(03)00170-X","article-title":"Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype","author":"Dhib S","journal-title":"<em>J Neuroimmunol<\/em>"},{"key":"104","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490400503","article-title":"Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells","author":"Issazadeh S, Mustafa M, Ljungdahl A, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"105","article-title":"Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery","unstructured":"105. Kennedy MK, Torrance DS, Picha KS, et al. (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. <em>J Immunol<\/em> 149: 2496."},{"key":"106","article-title":"IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state","unstructured":"106. Nishihara M, Ogura H, Ueda N, et al. (2007) IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. <em>Int Immunol <\/em>19: 695-702."},{"key":"107","doi-asserted-by":"publisher","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","author":"Immunology N","journal-title":"<em>Nat Immunol<\/em>"},{"key":"108","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","author":"Park H, Li Z, Yang XO, et al.","journal-title":"<em>Nat Immunol<\/em>"},{"key":"109","article-title":"Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications","unstructured":"109. Passos GRD, Sato DK, Becker J, et al. (2016) Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications. <em>Mediat Inflamm<\/em> 2016: 1-11."},{"key":"110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159565","article-title":"Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns","author":"Zahra S, Rozita D, Masoumeh B, et al.","journal-title":"<em>PLoS One<\/em>"},{"key":"111","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis","author":"Kebir H, Ifergan I, Alvarez JI, et al.","journal-title":"<em>Ann Neurol<\/em>"},{"key":"112","doi-asserted-by":"publisher","DOI":"10.1042\/BST0361120","article-title":"Exploring the mechanism of tryptophan 2,3-dioxygenase","author":"Thackray SJ, Mowat CG, Chapman SK","journal-title":"<em>Biochem Soc Trans<\/em>"},{"key":"113","article-title":"Endogenous kynurenines as targets for drug discovery and development","unstructured":"113. Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. <em>Nat Rev<\/em> 1: 609-620."},{"key":"114","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","author":"Munn DH, Mellor AL","journal-title":"<em>J Clin Invest<\/em>"},{"key":"115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","author":"Fallarino F, Grohmann U, You S, et al.","journal-title":"<em>J Immunol<\/em>"},{"key":"116","doi-asserted-by":"publisher","DOI":"10.2174\/138920007780362518","article-title":"Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines","author":"Mackenzie CR, Heseler K, M\u00fcller A, et al.","journal-title":"<em>Curr Drug Metab<\/em>"},{"key":"117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis","author":"Mancuso R, Hernis A, Agostini S, et al.","journal-title":"<em>Plos One<\/em>"},{"key":"118","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21081062","article-title":"Influence of Cysteine and Tryptophan Substitution on DNA-Binding Activity on Maize \u00ce\u00b1-Hairpinin Antimicrobial Peptide","author":"Sousa DA, Porto WF, Silva MZ, et al.","journal-title":"<em>Molecules<\/em>"},{"key":"119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.09.030","article-title":"Regulation of Th1\/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients","author":"Smith AW, Doonan BP, Tyor WR, et al.","journal-title":"<em>J Neuroimmunol<\/em>"},{"key":"120","article-title":"The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis","unstructured":"120. Cilingir V, Batur M, Bulut MD, et al. (2017) The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis. <em>Neurol Sci <\/em>38: 1223-1232."},{"key":"121","article-title":"Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis","unstructured":"121. Britze J, Pihljensen G, Frederiksen JL (2017) Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis. <em>J Neurol <\/em>264: 1837-1853<em>.<\/em>"},{"key":"122","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity","author":"Mowry EM, Loguidice MJ, Daniels AB, et al.","journal-title":"<em>J Neurol Neurosurg Psychia<\/em>"},{"key":"123","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000197","article-title":"Should patients with optic neuritis be treated with steroids","author":"Mackay DD","journal-title":"<em>Curr Opin Ophthalmol<\/em>"},{"key":"124","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-1869","article-title":"Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats","author":"Dimitriu C, Bach M, Lagr\u00e8ze WA, et al.","journal-title":"<em>Invest Ophthalmol Vis Sci<\/em>"},{"key":"125","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12064","article-title":"Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats","author":"Das A, Guyton MK, Smith A, et al.","journal-title":"<em>J Neurochem<\/em>"},{"key":"126","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)01381-4","article-title":"Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study","author":"Shields DC, Tyor WR, Deibler GE, et al.","journal-title":"<em>Brain Res<\/em>"},{"key":"127","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31829c7370","article-title":"Calcium influx and calpain activation mediate preclinical retinal neurodegeneration in autoimmune optic neuritis","author":"Hoffmann DB, Williams SK, BojcevskiJovana, et al.","journal-title":"<em>J Neuropathol Exp Neurol<\/em>"},{"key":"128","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.156612","article-title":"A novel calpain inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), reduces murine retinal cell death in vitro and in vivo","author":"Shimazawa M, Suemori S, Inokuchi Y, et al.","journal-title":"<em>J Pharm Exp Ther<\/em>"},{"key":"129","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.171298","article-title":"Calpain inhibitor protects cells against light-induced retinal degeneration","author":"Imai S, Shimazawa M, Nakanishi T, et al.","journal-title":"<em>J Pharm Exp Ther<\/em>"},{"key":"130","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.08.009","article-title":"The role of calpain in an in vivo model of oxidative stress-induced retinal ganglion cell damage","author":"Yokoyama Y, Maruyama K, Yamamoto K, et al.","journal-title":"<em>Biochem Biophys Res Comm<\/em>"},{"key":"131","article-title":"Protection against TBI-induced neuronal death with post-treatment with a selective calpain-2 inhibitor in mice","unstructured":"131. Wang Y, Liu Y, Lopez D, et al. (2017) Protection against TBI-induced neuronal death with post-treatment with a selective calpain-2 inhibitor in mice. <em>J Neurotrauma<\/em>."},{"key":"132","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.03.017","article-title":"Real-time imaging of RGC death with a cell-impermeable nucleic acid dyeing compound after optic nerve crush in a murine model","author":"Tsuda S, Tanaka Y, Kunikata H, et al.","journal-title":"<em>Exp Eye Res<\/em>"},{"key":"133","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22800","article-title":"Critical role of calpain in axonal damage-induced retinal ganglion cell death","author":"Ryu M, Yasuda M, Shi D, et al.","journal-title":"<em>J Neurosci Res<\/em>"},{"key":"134","article-title":"Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia","unstructured":"134. Nemeth CL, Drummond GT, Mishra MK, et al. (2017) Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia. <em>Nanomedicine <\/em>13: 2359-2369."},{"key":"135","article-title":"Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model","unstructured":"135. Zhang F, Trent MJ, Lin YA, et al. (2017) Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model. <em>J Control Release <\/em>249: 173-182."},{"key":"136","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000259521.14704.a8","article-title":"Natalizumab reduces visual loss in patients with relapsing multiple sclerosis","author":"Balcer LJ, Galetta SL, Calabresi PA, et al.","journal-title":"<em>Neurology<\/em>"},{"key":"137","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2006.04.015","article-title":"Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions","author":"S\u00e4ttler MB, Demmer I, Williams SK, et al.","journal-title":"<em>Exp Neurol<\/em>"},{"key":"138","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1788","article-title":"Axon degeneration mechanisms: commonality amid diversity","author":"Coleman M","journal-title":"<em>Nat Rev Neurosci<\/em>"}],"container-title":["AIMS Molecular Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/molsci.2017.4.446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T01:52:51Z","timestamp":1509069171000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/molsci.2017.4.446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3934\/molsci.2017.4.446","relation":{},"ISSN":["2372-0301"],"issn-type":[{"value":"2372-0301","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}